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Coronaviruses are the largest RNA viruses, and their genomes encode replication machinery capable of
efficient replication of both positive- and negative-strand viral RNAs as well as enzymes capable of processing
large viral polyproteins into putative replication intermediates and mature proteins. A model described
recently by Sawicki et al. (S. G. Sawicki, D. L. Sawicki, D. Younker, Y. Meyer, V. Thiel, H. Stokes, and S. G.
Siddell, PLoS Pathog. 1:e39, 2005), based upon complementation studies of known temperature-sensitive (TS)
mutants of murine hepatitis virus (MHV) strain A59, proposes that an intermediate comprised of nsp4 to
nsp10/11 (150 kDa) is involved in negative-strand synthesis. Furthermore, the mature forms of nsp4 to nsp10
are thought to serve as cofactors with other replicase proteins to assemble a larger replication complex
specifically formed to transcribe positive-strand RNAs. In this study, we introduced a single-amino-acid change
(nsp10:Q65E) associated with the TS-LA6 phenotype into nsp10 of the infectious clone of MHV. Growth kinetic
studies demonstrated that this mutation was sufficient to generate the TS phenotype at permissive and
nonpermissive temperatures. Our results demonstrate that the TS mutant variant of nsp10 inhibits the main
protease, 3CLpro, blocking its function completely at the nonpermissive temperature. These results implicate
nsp10 as being a critical factor in the activation of 3CLpro function. We discuss how these findings challenge
the current hypothesis that nsp4 to nsp10/11 functions as a single cistron in negative-strand RNA synthesis and
analyze recent complementation data in light of these new findings.
Coronaviruses (CoVs) are large single-stranded positive-
sense RNA viruses of the order Nidovirales, family Coronaviri-
dae, genus Coronavirus (16, 30, 34). They comprise viruses
known to cause severe disease in humans, such as severe acute
respiratory syndrome CoV (SARS-CoV), which causes an
atypical pneumonia with a 10% mortality rate (52). In addi-
tion, newly discovered human CoV strain NL63 (HCoV-NL63)
(57) and HCoV-HKU-1 (31) are associated with lower respi-
ratory tract infections, while HCoV-OC43 and HCoV-229E
are typically associated with milder infections similar to the
common cold (3). In addition, several CoVs are the etiological
agents responsible for diseases affecting important domestic
animals including bovines (bovine CoV), swine (porcine epi-
demic diarrhea virus and transmissible gastroenteritis virus),
and avians (infectious bronchitis virus) (3, 12, 30, 33). Murine
hepatitis virus (MHV) strain A59 (MHV-A59) has been ex-
tensively studied in cell culture and in mouse models (38), and
being a close relative of SARS-CoV makes it a relevant model
for studying HCoVs.
Upon entry into the cytoplasm of the infected cell, the viral
RNA, which is tightly associated with nucleocapsid protein
(N), is uncoated and immediately translated by host ribosomes
into large polyproteins (30, 33). Roughly the first two-thirds of
the CoV genome encodes the nonstructural replicase proteins
in a single open reading frame (ORF) (Fig. 1A). The final
one-third of the genome consists of the structural proteins
spike (S), envelope (E), matrix (M), and N (Fig. 1A) as well as
accessory proteins specific to different strains, which are trans-
lated from a nested set of coterminal subgenomic mRNAs (30,
33).
Two polyproteins are translated from the genome, with the
most abundant comprised of nsp1 to nsp10/11, known as
polyprotein 1a (pp1a), while the second is a fusion protein
known as pp1ab, comprised of nsp1 to nsp16 (30, 33) (Fig. 1A),
which is translated only following a ribosomal frameshift that
occurs with an approximate frequency of 25 to 30% (7, 8).
Processing of the polyproteins occurs both co- and posttrans-
lationally with two classes of viral proteinases required to
cleave the polyprotein into its component proteins and inter-
mediates (Fig. 1A). The first cleavage events in MHV require
the papain-like proteinases (PLPs) (PLP1 and PLP2), which
rapidly cleave nsp1 to nsp3 from the N terminus. nsp4 to nsp16
are processed by a second 3C-like proteinase known as 3CLpro
or Main proteinase (Mpro). A precursor intermediate of 150
kDa, comprised of nsp4 to nsp10/11 (Fig. 1A), has been de-
tected in pulse-chase experiments and is thought to play a role
in CoV replication (24, 50), although its exact function is yet to
be determined. The mature processed proteins are predicted
to form the replication complex (9, 10, 15, 22, 50, 61). To date,
only nsp2 has been shown to be dispensable for MHV repli-
cation (21).
Studies with the 3CLpro inhibitor E64d have demonstrated
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that the addition of this cysteine-specific proteinase inhibitor
to cells infected with MHV-A59 rapidly shuts off new viral
RNA synthesis, demonstrating that the processing of pp1a/
pp1ab is required throughout the infection to sustain the RNA
synthesis necessary for viral replication (27).
Coronavirus replication is currently thought to require at
least four distinct phases: (i) recruitment of viral RNA from
translation to sites of negative-strand synthesis, (ii) negative-
strand synthesis of full-length genomic RNA and subgenome-
length transcripts, (iii) conversion from negative- to posi-
tive-strand synthesis, and (iv) positive-strand synthesis of
genome- and subgenome-length transcripts (37, 46, 47, 61).
The exact mechanism and proteins or intermediates required
for negative- and positive-strand synthesis are currently not
known (47). However, it has been shown that continued pro-
cessing of the viral polyprotein is essential for continued neg-
ative-strand synthesis (47, 59), suggesting that polyprotein in-
termediates are required to replicate negative strands and that
these are then processed into mature proteins that presumably
assemble and function as the positive-strand replication com-
plex (47). In contrast, the positive-strand replication complex
does not appear to require additional polypeptide processing,
as positive-strand synthesis continues unabated and slowly de-
cays after treatment of cells with cycloheximide (CH), while
negative-strand synthesis stops abruptly (47, 59).
A recent model proposes that negative-strand synthesis is
facilitated by the use of a replication protein intermediate that
is hypothetically processed into mature proteins that form the
positive-strand replication complex at later times during infec-
tion (47). This model is supported by classical complementa-
tion studies conducted with temperature-sensitive (TS) mu-
tants that suggest that the nsp4 to nsp10/11 intermediate, with
a molecular mass of 150 kDa (p150), functions as a single
polyprotein or functions in cis before processing to synthesize
negative strands, as TS mutations found in nsp4, nsp5, and
nsp10 did not complement each other (47). A single point
mutation in nsp10, a glutamine-to-glutamate change at posi-
tion 65 of this protein, was predicted to be responsible for the
TS phenotype and halts negative-strand synthesis upon a shift
from a permissive to a nonpermissive temperature (32°C and
39.5°C, respectively), an observation later characterized as a
defect in negative-strand elongation (47, 59). These data sug-
gest that the p150 intermediate plays a functional role in neg-
ative-strand synthesis, that nsp10 functions in negative-strand
elongation as part of the p150 intermediate, and that nsp10 in
its mature form may play a role in positive-strand synthesis (47,
59).
The goal of this study was to further characterize the TS
mutant of nsp10 to advance our understanding of the role of
nsp10 in CoV replication. Using a genetic approach, we dem-
onstrate that a single glutamine-to-glutamic acid replacement
at position 65 of nsp10 confers the TS phenotype characterized
by a complete block in 3CLpro cleavage of the viral polypro-
tein at the nonpermissive temperature.
MATERIALS AND METHODS
Virus and cells. For this study, we used MHV-A59 generated from the infec-
tious clone (60) (wt-icMHV) as the wild-type control, and the TS mutant was
engineered into the MHV clone, which is comprised of seven fragments main-
tained in plasmids amplified and assembled according to previously described
protocols (60) (Fig. 1B). Briefly, plasmids were transformed into chemically
competent Top10 cells (Invitrogen) by heat shock at 42°C for 2 min and then
plated onto Luria-Bertani (LB) plates. Colonies were picked and grown under
appropriate selection in LB broth maintained at 28.5°C for 16 to 24 h. Delayed
brain tumor (DBT) cells were maintained at 37°C in minimum essential medium
FIG. 1. Polyprotein processing of MHV-A59 and assembly of MHV and TS-LA6 infectious clones. (A) pp1a and pp1ab, encoded by ORF1a
and ORF1ab, are processed by two virally encoded proteinases into 16 mature proteins. PLP1 and PLP2 cleave the first three nsp’s, while 3CLpro
cleaves nsp4 to nsp16. The p150 intermediate is comprised of nsp4 to nsp10/11. T1, transmembrane region 1; T2, transmembrane region 2; T3,
transmembrane region 3; 3CL, 3CLpro; RdRp, RNA-dependent RNA polymerase; Hel, helicase; ExoN, exoribonuclease; XendoU, endonuclease;
MT, methyltransferase. Black boxes indicate structural proteins that comprise roughly one-third of the genome, and the hatched box represents
the nsp that contains the mutations of interest. (B) The MHV infectious clone is divided into seven fragments, which are assembled after unique
restriction sites are used to digest the cDNA from plasmids, and appropriate sticky ends allow the fragments to ligate together in the proper order
and orientation. The MHV-E fragment was mutated to generate the icTS-LA6 mutant.
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supplemented with 10% Fetal Clone II (Gibco), 10% tryptose phosphate broth,
and gentamicin (0.05 g/ml)-kanamycin (0.25 g/ml). Baby hamster kidney
(BHK) cells exogenously expressing MHV receptor (BHK-MHVr) were main-
tained at 37°C in the same media described above with the addition of geneticin
(0.8 mg/ml) to select for cells expressing MHV receptor.
Generating the TS mutant TS-LA6. The mutation of interest, a glutamine-to-
glutamate change at amino acid position 65 in nsp10 (51), located from positions
13359 to 13361 on the MHV-A59 genome (GenBank accession number
NC_001846), was mapped to the MHV-E fragment of the molecular clone (Fig.
1B and 2B). This fragment was used to engineer the appropriate mutation into
the MHV backbone. Primers that incorporated a type IIs restriction endonucle-
ase (BbsI) site flanking the mutation of interest, and which introduced two
nucleotide changes within the codon being targeted, were designed (Table 1).
Mutated fragments were generated by PCR, cloned into the TopoXL vector
(Invitrogen), grown up in competent Top10 cells, screened by restriction diges-
tion, and sequenced to verify that the correct changes were incorporated. The
full-length infectious clone was assembled as previously described (60), as was
the mutant incorporating the mutant MHV-E fragment (Fig. 1B). The full-length
cDNA construct was transcribed and transfected into 8  106 BHK-MHVr cells,
poured onto 5  106 DBT cells (60), and incubated at the permissive tempera-
ture of 32°C for 24 to 72 h. Flasks were examined at regular intervals for a
cytopathic effect (CPE) and verified by reverse transcriptase PCR (RT-PCR) of
subgenomic RNA using primers targeting the leader sequence and the 5 end of
the N gene (Table 1). Rescued virus was plaque purified, and the nsp10 gene was
amplified by RT-PCR, cloned into the TopoXL vector, and sequenced to confirm
that the correct mutations were present in the recombinant virus (Fig. 2B). The
sequence-verified mutant virus was designated infectious clone of TS-LA6 (icTS-
LA6).
Growth kinetics and temperature shift experiments. Viral stocks of recombi-
nant wt-icMHV were propagated in DBT cells grown at 37°C, while mutant
icTS-LA6 was propagated in DBT cells maintained at the permissive tempera-
ture of 32°C. Titers were determined by plaque titration in DBT cells maintained
at the appropriate temperature. For the temperature-specific plaque assay, DBT
cells were infected in duplicate with serial dilutions of wt-icMHV or icTS-LA6 in
60-mm plates with a 1-h adsorption period. Five milliliters of overlay agar (0.8%
LE agar [Sigma], 10% Fetal Clone II, 40% 2 minimum essential medium, 1%
gentamicin-kanamycin) was added to each culture, and the infections were main-
tained at both 32°C and 39.5°C until plaques were observed between 24 h and
36 h. To visualize plaques, plates were stained with neutral red for 2 h at 32°C
and counted.
For the growth curve analysis, cultures of DBT cells were infected at a mul-
tiplicity of infection (MOI) of 1 PFU/cell in 60-mm plates with a 1-h adsorption
period, followed by three washes with phosphate-buffered saline. Three millili-
ters of medium was added to each culture, and the infections were maintained at
32°C. Supernatants were harvested at 2, 4, 6, 9, 12, and 16 h postinfection (p.i.),
and titers determined by plaque titration in DBT cells maintained at 32°C.
The temperature shift growth curves were conducted as previously described
(49), with slight modifications. Briefly, multiple 60-mm dishes of DBT cells were
infected with wt-icMHV and mutant icTS-LA6 at an MOI of 5 PFU/cell and
incubated at the permissive temperature of 32°C for 6 h. At 6 h, half of the
cultures were shifted to the nonpermissive temperature of 39.5°C. Supernatant
samples were taken from both 32°C and 39.5°C cultures at 2, 4, 6, 9, and 12 h p.i.,
and titers were determined by plaque titration in DBT cells maintained at 32°C.
RNA analysis. DBT cells were infected in triplicate with wt-icMHV or icTS-
LA6 at an MOI of 1 PFU/cell and maintained at 32°C, 37°C, or 39.5°C. At 8 h
p.i., cells were harvested in TRIzol reagent (Invitrogen) for isolation of total
TABLE 1. Primers used for engineering of nsp10 mutants and RT-PCR
Primer Sequence (5–3) Sense Purpose
icTS-LA6S GAAGACGAAGATTCTTATGGTGGTGCTTCC  Mutant icTS-LA6
icTS-LA6A GAAGACGAATCTTCATTAGTGGTTGCCTCCGGC  Mutant icTS-LA6
nsp10-WS ACAGGGTGGAGTTCCCGTTA  PCR and sequencing of nsp10
nsp10-WA CCTAAGGGCACTTGGACAAA  PCR and sequencing of nsp10
Sg-N1S AAGAGTGATTGGCGTCCGTA  RT and quantitative PCR
Sg-N1A AGCGCGGTTTACAGAGGAG  RT and quantitative PCR
FIG. 2. Verification of viral replication and genotype. (A) Transfected cells were harvested in TRIzol reagents, and total RNA was extracted
and reverse transcribed. The cDNA was amplified by PCR with primers designed to detect leader-containing cDNAs (N gene and leader). Bands
correspond in size to subgenomic mRNAs for N, M, E, and S (lane 2). (B) Mutant viruses were plaque purified, and the nsp10 region was amplified
by RT-PCR and cloned into TopoXL for sequencing. The sequence read of the PCR product shows that the mutation was present in the
plaque-purified virus.
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RNA and probed for viral mRNA production. For Northern blot analysis, 1 g
of total RNA from mutant icTS-LA6 and wt-icMHV at each temperature was
separated by gel electrophoresis on a 1% agarose gel, transferred onto a nitro-
cellulose membrane, and probed with a 300-nucleotide (nt) biotinylated RNA
probe designed to detect the first 300 nt of mRNA-7 (N gene) using an Ambion
(Austin, TX) Northern kit. Bands were detected using the Bright Star Detection
(Ambion) system, and membranes were exposed to film.
Reverse transcription, RT-PCR, and real-time PCR. Viral RNA was then
reverse transcribed to cDNA using SuperScript III (Invitrogen) with modifica-
tions to the protocol as follows. Random hexamers (300 ng) and total RNA (5
g) were incubated for 10 min at 70°C. The remaining reagents were then added
according to manufacturer’s protocol, and the reaction mixture was incubated at
55°C for 1 h followed by 20 min at 70°C to deactivate the RT. For RT-PCR, a
forward primer in the leader sequence and a reverse primer 200 nt into the N
gene (Table 1) were used to generate a 220-bp product by PCR.
Real-time PCR was conducted using Smart Cycler II (Cepheid) with SYBR
green (diluted to 0.25; Cepheid) to detect subgenomic cDNA with primers (7.5
pM) optimized to detect 120 nt spanning from the leader sequence to the 5
end of the N gene (Table 1) or genomic cDNA with primers (7.5 pM) optimized
to detect 120 nt of ORF1a (Table 1). cDNA template concentrations from the
RT reaction mixture were diluted 1:100 and normalized to concentrations of
the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Omnimix beads (Cepheid) containing all reagents except SYBR green, primer,
and template were used to standardize the reaction conditions. All product sizes
were verified by melting curve analysis.
Immunoprecipitation analysis. DBT cells were infected at an MOI of 2 PFU/
cell for 2 h, at which time the medium was removed and replaced with medium
lacking Met-Cys but containing 20 g/ml of actinomycin D (Sigma), and incu-
bated at 32°C for icTS-LA6 and TS-LA6 and 37°C for wt-icMHV for an addi-
tional 2 h. At 4 h p.i., [35S]methionine-cysteine (0.08mCi/ml) was added to the
infections, and cells were harvested at 9 h. Radiolabeled cells were washed in 1
ml of phosphate-buffered saline and then resuspended in 1 ml of cold ST buffer
(200 mM sucrose, 10 mM Tris[pH 7.4]). Next, the cells were homogenized by 40
passes through a ball-bearing homogenizer and transferred into fresh tubes.
Homogenates were then spun at 6,000  g for 3 min at room temperature, and
the supernatant was transferred into ultracentrifuge tubes and spun at 300,000 
FIG. 3. Growth characteristics of TS mutant icTS-LA6. (A) A plaque assay was performed to determine if icTS-LA6 produced plaques at the
permissive and nonpermissive temperatures. wt-icMHV (hatched bars) grew at the permissive and nonpermissive temperatures, while icTS-LA6
(solid bars) produced plaques only at the permissive temperature. (B) Virus growth was evaluated at the permissive temperature for wt-icMHV
() and icTS-LA6 (F). wt-icMHV was delayed in growth at 32°C from 9 to 14 h but recovered by 16 h. (C and D) A temperature shift experiment
was performed using double cultures of cells infected at an MOI of 1 PFU/cell with the infection initiated at 32°C. At 6 h (indicated by arrow),
half of the cultures were shifted to the nonpermissive temperature, supernatants were harvested at 2, 4, 6, 9, and 12 h p.i. from both cultures, and
titers were determined by plaque assay. wt-icMHV grew equally well at both temperatures (C), while icTS-LA6 shows a TS phenotype, with growth
declining rapidly after a shift to the nonpermissive temperature (D). f, infections initiated and maintained at 32°C; Œ, infections initiated at 32°C
and shifted to 39.5°C at 6 h p.i.
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g for 15 min at 4°C. The supernatant was then transferred into a fresh tube
(S100), and the pellet was resuspended in 1 ml of ST buffer (P100).
Lysates were boiled for 5 min in sodium dodecyl sulfate (SDS) at a final
concentration of 1% and then combined with protein A-Sepharose beads and a
1:200 dilution of anti-nsp10 antibody (VU128) in no-SDS lysis buffer (1% NP-40,
150 mM sodium chloride, 0.5% sodium deoxycholate, and 50 mM Tris [pH 8.0])
supplemented with 1% SDS. After incubation at 4°C for 4 h, the beads were
pelleted and washed with low-salt lysis buffer (no-SDS lysis buffer plus 150 mM
NaCl), followed by high-salt lysis buffer (no-SDS lysis buffer with 1 M NaCl) and
a final low-salt wash. After rinsing, 30 ml of 2 SDS loading buffer (8% SDS, 0.2
M Tris [pH 8.8], 4 mM EDTA, 0.1% bromophenol blue, 40% glycerol, 0.5 M
dithiothreitol) was added to the pelleted beads and boiled for 5 min prior to
electrophoresis of the supernatant on 4 to 12% SDS-polyacrylamide gel electro-
phoresis (PAGE) gels.
Temperature shift immunoprecipitation analysis. DBT cells were infected in
duplicate with mock, wt-icMHV, icTS-LA6, and TS-LA6 at an MOI of 10
PFU/cell at the permissive temperature of 32°C for 1 h, at which time the
medium was removed and replaced with medium lacking Met-Cys but containing
20 g/ml of actinomycin D and incubated at the permissive temperature for an
additional 3 h. At 4 h p.i., 35S-labeled Cys-Met (0.08 mCi/ml) medium was added
to the infected cells, and half the cultures were shifted to the nonpermissive
temperature of 39.5°C. Cell lysates were harvested at 8 h p.i., and the cytoplasmic
fraction was processed and prepared for SDS-PAGE as described above using
antibodies directed against nsp10, nsp8, nsp5, nsp12, nsp2, and MHV (VU128,
VU123, SP9, VU145, VU154, and VU13, respectively).
Analysis of structure. The crystal structure coordinates of SARS-CoV nsp10
(Protein Data Bank [PDB] accession number 2FYG) (23) were used to generate
a homology model of MHV nsp10 and icTS-LA6 using the program Modeler
version 8.2 (17, 32), implementing the automodel class. A pairwise alignment was
generated using the SARS-CoV nsp10 PDB file and the MHV homologue
sequence (GenBank accession number NP_740615), and five models were gen-
erated from each alignment, with the best model selected based on the lowest
objective function score. Corresponding PDB files generated by this program
were visualized using the molecular modeling tools MacPyMol (DeLano Scien-
tific) and Chimera (39). In addition, the program Rosetta was used to generate
a robust structural model of icTS-LA6, using a flexible backbone as well as
relaxed rotameric states to estimate the lowest-energy putative structure (35).
RESULTS
Assembling infectious clone TS-LA6. The Q65E mutation of
nsp10 predicted by sequence analysis to convey a TS pheno-
type capable of growth only at the permissive temperature of
32°C (51) was engineered into the infectious clone of MHV
(Fig. 1A and B). This experiment was designed to confirm that
a single amino acid replacement could recapitulate the TS-
LA6 phenotype as reported previously by Siddell et al. (51).
The mutation was engineered into the MHV-E fragment using
the No See’m approach described previously (60) and outlined
above (Fig. 1B). The seven fragments of the molecular clone
were ligated together with the appropriate mutant fragment,
and full-length cDNAs were transcribed in vitro, transfected
into BHK-MHVr cells, poured onto DBT cells, and monitored
for CPE. For wt-icMHV, transfections were maintained at
37°C, while mutant icTS-LA6 was maintained at the permissive
temperature of 32°C. Plates were examined at regular intervals
for CPE, indicated by syncytium formation and clearing of the
monolayer.
Rescue of recombinant virus bearing the TS-LA6 genotype.
wt-icMHV showed obvious CPE by 6 h posttransfection, with
the cultures displaying extensive CPE and fusion by 16 h post-
transfection. In contrast, icTS-LA6 was delayed in the onset of
CPE, although cytopathology was clearly detectable at 24 h
posttransfection. The delay in the CPE phenotype was likely
associated with the maintenance of the cultures at 32°C, the
permissive temperature for TS-LA6 replication. Replication
was verified by RT-PCR using primers to detect products that
contain the leader sequence and a 5 portion of the N gene
(Fig. 2A and Table 1). icTS-LA6 was plaque purified, and
stocks were grown to high titers for additional analyses. Cells
infected with plaque-purified virus were harvested, and the
nsp10 region was amplified by RT-PCR and sequenced to
verify that the Q65E mutation was present. All five plaques
selected and sequenced showed the correct mutation at posi-
tion 65 of nsp10 (Fig. 2B).
wt-icMHV produced clear plaques of about 5 mm by 24 to
36 h posttransfection, while icTS-LA6 produced smaller, less
distinct plaques that were harder to see in the monolayer and
identical to plaques produced by infection with TS-LA6. Our
next step was to verify the TS phenotype of icTS-LA6.
Characterization of the TS phenotype of icTS-LA6. First,
serial dilutions of supernatant from plaque-purified virus was
used to infect double cultures of DBT cells maintained at the
permissive temperature of 32°C and the nonpermissive tem-
perature of 39.5°C, with plaques counted at 36 h p.i. wt-icMHV
produced plaques at both temperatures and reached a titer of
1  108 PFU/ml under both conditions, while icTS-LA6 pro-
duced a titer of 8  107 PFU/ml at the permissive temperature
but produced no plaques at the nonpermissive temperature
(Fig. 3A). This phenotype was the same as that of TS-LA6,
which has a known reversion frequency of 1  108 (46). Next,
DBT cells were infected at an MOI of 1 PFU/cell for 1 h, and
virus growth was assayed over 16 h for both icTS-LA6 and
wt-icMHV at the permissive temperature. icTS-LA6 and wt-
icMHV grew to nearly the same titers at all time points, except
at 12 h, where the wild type was delayed in replication by 1 log
compared to icTS-LA6 (Fig. 3B), and these results were con-
sistent with those for TS-LA6.
A temperature shift assay was performed to further evaluate
the TS phenotype of icTS-LA6. Dual infections with wt-
icMHV and icTS-LA6 were initiated at the permissive tempera-
ture of 32°C at an MOI 5 PFU/cell, and at 6 h p.i., half the
cultures were shifted to the nonpermissive temperature of
39.5°C (49). wt-icMHV grew to similar titers at each time point
and at both temperatures (Fig. 3C). However, after a shift to
the nonpermissive temperature, growth of icTS-LA6 was in-
hibited, and titers dropped 3 and 4 logs below those of cultures
maintained at 32°C at the later time points (Fig. 3D). In all
cases tested, icTS-LA6 behaved identically to TS-LA6 as reported
previously (49). Clearly, the amino acid change identified previ-
ously by Siddell et al. is sufficient for the TS phenotype noted for
TS-LA6 (51).
RNA synthesis of icTS-LA6 mimics RNA synthesis of wt-
icMHV at the permissive temperature. DBT cells were in-
fected at an MOI of 1 PFU/cell with wt-icMHV or icTS-LA6
and maintained at 32°C, 37°C, or 39.5°C for 8 h. The superna-
tant was removed, and the cells were harvested using TRIzol
reagents. Total RNA (1 g) was denatured with glyoxal and
separated on 1% agarose gels. The RNA was transferred onto
a nitrocellulose membrane and probed for virus mRNAs using
an RNA probe designed to hybridize to the first 300 nt of the
N gene found at the 5 end of genomic RNA and all sub-
genomic mRNAs. icTS-LA6 and wt-icMHV produced nearly
identical levels of subgenomic mRNA at the permissive tem-
perature (Fig. 4). We were unable to detect mRNA in cells
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infected with icTS-LA6 maintained at 37°C or 39.5°C (data not
shown).
To confirm and extend the Northern blot analysis, real-time
PCR analysis was used to quantify viral transcripts using prim-
ers designed to amplify cDNAs from the N gene or genomic
RNA. Quantitative RT-PCR analyses also demonstrated that
mutant icTS-LA6 and wt-icMHV showed equivalent quantities
of genomic and subgenomic mRNA at 8 h p.i. at the permissive
temperature (Fig. 5B and C). Both were reduced compared to
wt-icMHV infections initiated and maintained at 37°C (Fig. 5B
to D). A comparison of ratios of subgenomic N-gene mRNA to
genomic RNA demonstrated that mutant icTS-LA6 had equal
reductions in both subgenomic and genomic mRNAs, resulting
in ratios similar to those of the wild type (100 to 1) (Fig. 5D)
(46, 47). These results suggested that this mutation had little
effect on plus- or minus-strand RNA synthesis at the permis-
sive temperature. Little if any subgenomic or genomic RNA
was detected by real-time PCR in DBT cells infected with
icTS-LA6 maintained at the nonpermissive temperature.
Processing of nsp10 is not altered in mutant icTS-LA6 at the
permissive temperature. We next examined nsp10 processing
to determine if nsp10 was cleaved from the polyprotein at rates
equal to those of wt-icMHV. To evaluate protein processing
and expression of nsp10, DBT cells were infected with wt-
icMHV, TS-LA6, or icTS-LA6, and the cultures were labeled
with [35S]Cys-Met for 3 h between 7 and 9 h p.i. nsp4 to
nsp10/11 are expressed as a large precursor of 150 kDa (p150),
which is subsequently processed by cis and/or trans cleavage
into the individual replicase proteins nsp4 to nsp10. A band
corresponding to the p150 intermediate was detected, as were
bands corresponding to processed nsp10 (Fig. 6A). TS-LA6
and icTS-LA6, grown at the permissive temperature of 32°C,
processed similar levels of the p150 intermediate and nsp10,
and both were reduced compared to wild-type MHV-A59
grown at 37°C (Fig. 6A). Both TS mutants processed equiva-
lent structural proteins compared to those of wt-icMHV (Fig.
6B).
Mutations responsible for the TS phenotype completely
block 3CLpro activity at the nonpermissive temperature. To
determine levels of nsp10 processing at the permissive and
nonpermissive temperatures, temperature shift immunopre-
cipitation assays were designed and conducted to analyze the
processing of nsp10 at 32°C and after a shift to 39.5°C. DBT
cells were infected in duplicate with mock, wt-icMHV, icTS-
LA6, and TS-LA6 at an MOI of 10 PFU/cell at the permissive
temperature of 32°C for 1 h, after which the medium was
removed and replaced with medium lacking Met-Cys but con-
taining 20 g/ml of actinomycin D and incubated at the per-
missive temperature for an additional 3 h. At 4 h p.i., 35S-
labeled Cys-Met (0.08 mCi/ml) medium was added to the
infected cells, and half the cultures were shifted to the non-
permissive temperature of 39.5°C. Cell lysates were harvested
at 8 h p.i., and the cytoplasmic fraction was probed with anti-
bodies directed against nsp10 (VU128), separated on SDS-
PAGE gels, and analyzed by autoradiography to detect radio-
labeled viral proteins. At 32°C, nsp10 was processed as
expected for infections with wt-icMHV, TS-LA6, and icTS-
LA6, and the p150 intermediate was detected in all cases (Fig.
7A, lanes 2 to 4). However, at 39.5°C, there was an accumu-
lation of p150 in TS-LA6 and icTS-LA6, and nsp10 processing
was abrogated in both TS mutants (Fig. 7A, lanes 6 and 7).
wt-icMHV continued to process nsp10 and p150 at all three
temperatures, 32°C, 37°C, and 39.5°C (Fig. 7A, lanes 2, 5,
and 8).
To determine if this effect was limited to nsp10, we next
examined the processing of nsp8 under the same experimental
conditions. Cell lysates were harvested, and the cytoplasmic
fraction was probed with antibodies directed against nsp8
(VU123), separated on SDS-PAGE gels, and analyzed by au-
toradiography to detect radiolabeled viral proteins. As with
nsp10, in the TS mutants TS-LA6 and icTS-LA6, nsp8 was
processed at the permissive temperature (Fig. 7B, lanes 3 and
4) but not at the nonpermissive temperature (Fig. 7B, lanes 6
and 7), while wt-icMHV processed nsp8 at all temperatures
(Fig. 7B, lanes 2, 5, and 8). The absence of nsp8 processing
again resulted in an accumulation of the p150 intermediate in
the TS infections shifted to the nonpermissive temperature.
To determine the extent of this effect, we next examined the
nsp5 (3CLpro) protein under identical conditions using anti-
nsp5 antibody (SP9) (Fig. 7C). Again, we discovered that the
infection with icTS-LA6 and TS-LA6 completely blocked pro-
cessing of nsp5 at the nonpermissive temperature after the
shift (Fig. 7C, lanes 6 and 7) but not before the shift (Fig. 7C,
lanes 3 and 4). These experiments demonstrated that the TS
mutation in nsp10 was sufficient to block the processing of the
C-terminal nsp5 to nsp10 of pp1a. To determine if the nsp10
mutation abrogated pp1ab processing, we performed the same
experiment using anti-nsp12 antibody (VU145) to analyze the
processing of RNA-dependent RNA polymerase at the per-
missive and nonpermissive temperatures (Fig. 7D). Surpris-
ingly, while wt-icMHV processed nsp12 at both temperatures
FIG. 4. Northern blot analysis of icTS-LA6. Cultures of cells were
infected at an MOI of 1 PFU/cell, and intracellular RNA was isolated
at 8 h p.i. The RNA was separated on 1% agarose gels, blotted onto a
nitrocellulose membrane, and probed with an MHV N-gene-specific
probe. icTS-LA6 and wt-icMHV grown at the permissive temperature
of 32°C generate equivalent quantities of subgenomic RNA at 8 h p.i.
Numbered bands correspond to mRNAs 1 to 7.
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(Fig. 7D, lanes 3 and 4), both TS-LA6 and icTS-LA6 did not
process nsp12 at the nonpermissive temperature (Fig. 7D,
lanes 6 and 7). This suggested that the TS mutation was re-
sponsible for a complete block of the 3CLpro activity.
To rule out a complete block in polyprotein processing, we
next precipitated nsp2 with an anti-nsp2 antibody (VU154)
from the same lysates to determine if nsp2 processing by PLP1
was affected at the nonpermissive temperature (Fig. 7E). In
this case, cells infected with wt-icMHV, icTS-LA6, and TS-
LA6 processed nsp2 at both the permissive and nonpermissive
temperatures (Fig. 7E, lanes 3, 4, 6, and 7). These results
demonstrate that the mutation in nsp10 responsible for the TS
phenotype completely blocks 3CLpro activity at the nonper-
missive temperature but has no effect on processing mediated
by PLPs.
TS mutation maps to a disordered region of nsp10, which
likely plays a role in 3CLpro processing. Homology models of
nsp10 were generated for wt-icMHV and icTS-LA6. The back-
bone of the SARS-CoV nsp10 structure (23) was then com-
pared to the homology model of MHV nsp10 using the Match-
Maker tool under the structure comparison section of Chimera,
resulting in a calculated root mean square distance of 0.207 Å.
FIG. 5. Real-time PCR analysis of icTS-LA6. Cells were infected in triplicate with wt-icMHV, icTS-LA6, and mock at an MOI of 1 PFU/cell
and maintained at the permissive temperature of 32°C and the standard temperature of 37°C. Cells were harvested in TRIzol reagent at 8 h p.i.,
total RNA was isolated, and 5 g of RNA was used for reverse transcription using random hexamer primers to generate cDNA. Viral cDNAs were
normalized to the housekeeping gene GAPDH. (A) Dilutions were prepared to normalize the total cDNA of all infections to approximate levels
using the housekeeping gene GAPDH. All four normalized samples amplified at similar cycle threshold values indicating equivalent starting
template concentrations. (B) Subgenomic mRNAs were detected using primers to the leader and the first 122 nt of the N gene. Cells infected with
wt-icMHV and maintained at 37°C generated the most subgenomic mRNAs, while cells infected with wt-icMHV and icTS-LA6 and maintained
at the permissive temperature were reduced by 2.5 logs. icTS-LA6 infections initiated and maintained at 37°C generated extremely reduced
concentrations of subgenomic mRNAs. (C) Genomic mRNAs were detected using primers to 122 nt of ORF1a. Cells infected with wt-icMHV and
maintained at 37°C generated the most genomic mRNAs, while cells infected with wt-icMHV and icTS-LA6 and maintained at the permissive
temperature were reduced by 2 to 2.5 logs. icTS-LA6 infections initiated and maintained at 37°C generated extremely reduced concentrations of
genomic RNAs. (D) Comparisons of the reductions of subgenomic and genomic mRNAs for icTS-LA6 and wt-icMHV suggest that RNA synthesis
is equivalent in both viruses at the permissive temperature. Black, subgenomic; white, genomic.
7092 DONALDSON ET AL. J. VIROL.
The homology models of nsp10 of icTS-LA6 and wt-icMHV were
then analyzed and compared.
In general, the nsp10:Q65E mutation occurs in a loop region
distal to both zinc-binding fingers (23), in a disordered region
that extends to the surface (Fig. 8) (14a). The switch from Gln
to Glu alters the surface charge by adding a negative charge to
the surface. In addition, both Modeler and Rosetta indicate
that this single amino acid change significantly alters the loop
structures in the region, resulting in an extended surface area
proximal to the mutation.
DISCUSSION
TS mutants have been described for a large number of pos-
itive-strand RNA viruses and have provided significant insights
into the molecular mechanisms governing RNA synthesis, ge-
nome replication, and subgenomic transcription (11, 18, 19, 25,
26, 28, 29, 41–44, 46, 48, 49, 55). In this study, we introduced
the Q65E mutation in nsp10 of MHV, which was predicted to
generate a TS phenotype (51), into the molecular clone of
MHV (Fig. 1) and recapitulated TS-LA6 as icTS-LA6 (Fig. 1
and 2). This confirms that this single amino acid replacement
is sufficient to generate this phenotype, and our characteriza-
tion experiments show that it clearly mimics the TS phenotype
reported for TS-LA6 (Fig. 3) (46, 48, 49, 51, 59). The mutation
was introduced by altering the codon in two positions to limit
reversion to the wild type and further stabilize the mutant
locus. No plaques were detected in infections initiated and
maintained at the nonpermissive temperature (Fig. 3A), while
icTS-LA6 grew with growth kinetics similar to those of the wild
type at the permissive temperature (Fig. 3B). A temperature
shift experiment confirmed that icTS-LA6 replication was sim-
ilar to that of wt-icMHV at the permissive temperature, but
replication declined drastically when shifted to the nonpermis-
sive temperature at 6 h p.i. (Fig. 3C and D). This result was in
complete agreement with data previously reported for TS-LA6
that showed an identical phenotype (48, 49).
In addition, at the permissive temperature, icTS-LA6 be-
haves similarly to the wild type in the processing of nsp10, as
detected by immunoprecipitation with anti-nsp10 antibody
(Fig. 6A), and in producing structural proteins, as indicated by
immunoprecipitation with anti-MHV antibody (Fig. 6B). Fur-
ther immunofluorescence assays conducted at 6.5 h p.i. showed
that in both wt-icMHV and TS-LA6, nsp10 colocalized with N
to sites of viral replication, indicating that the TS mutation in
nsp10 does not result in a defect in localization (data not
shown).
Analysis of RNA synthesis by real-time PCR (Fig. 5) and
Northern blotting (Fig. 4) showed that icTS-LA6 does not have
a specific defect in RNA synthesis, as it produces a wild-type
ratio of subgenomic-to-genomic mRNAs at the permissive
temperature (Fig. 5B, C, and D). Taken together, these data
suggest that the TS defect exhibited by icTS-LA6 has little or
no effect on RNA synthesis, subcellular localization, or nsp10
processing compared to wt-icMHV at the permissive temper-
ature.
Complementation studies using TS mutants with mutations
in several nsp’s of MHV have purported that nsp10 along with
nsp4, nsp5, nsp12, nsp14, and nsp16 are essential for the as-
sembly of a functional replication/transcription complex (46).
Among these TS mutants, three that fall within the peptide
sequence of pp1a have been identified, and these include TS-
ALB6 in nsp4, TS-ALB16 in nsp5, and TS-LA6 in nsp10.
Classic complementation experiments demonstrated that these
mutants do not complement each other in crosses where each
of the TS viruses was used to coinfect cells initiated and main-
tained at the nonpermissive temperature for a single round of
replication (8 h) (46). By definition, mutations that do not
complement each other in the cis-trans test are defined as a
FIG. 6. Processing of nsp10 and the structural proteins. Immunoprecipitations were conducted to evaluate the processing of nsp10 and the
structural proteins S, M, and N. Cells were infected at an MOI of 2 PFU/cell with infections initiated and maintained at the permissive temperature.
(A) Anti-nsp10 antibody was used to immunoprecipitate proteins from the cytoplasmic fraction of cells. nsp10 was detected and processed at the
permissive temperature, as was the p150 intermediate. (B) Anti-MHV antibody was used to detect structural proteins in wt-icMHV grown at 37°C
and compared to icTS-LA6 and TS-LA6 grown at 32°C.
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FIG. 7. Temperature shift immunoprecipitations of icTS-LA6. Double cultures of DBT cells were infected with mock (M) (lane 1), wt-icMHV (lanes
2 and 5), icTS-LA6 (lanes 3 and 6), and TS-LA6 (lanes 4 and 7) at an MOI of 10 PFU/cell at the permissive temperature of 32°C for an hour, medium
was then removed and replaced with medium lacking Met-Cys but with actinomycin D, and infections were incubated at the permissive temperature for
an additional 3 h. At 4 h p.i., labeled medium was added to the infected cells, and half the cultures were maintained at the permissive temperature (P),
while the other half were shifted to the nonpermissive temperature of 39.5°C (NP). Immunoprecipitations were performed on the cytoplasmic lysates
using antibodies indicated above each figure. wt-icMHV infections initiated and maintained at 37°C were performed as a control (C). (A) Immunopre-
cipitation analysis was performed using anti-nsp10 antibody (-nsp10). At the permissive temperature of 32°C, nsp10 is processed in wt-icMHV,
icTS-LA6, and TS-LA6 (lanes 2 to 4). For infections initiated at 32°C and then shifted to the nonpermissive temperature of 39.5°C, processing of nsp10
was ablated in icTS-LA6 and TS-LA6, while p150 appeared to accumulate (lanes 6 and 7). wt-icMHV continued to efficiently process this protein at 37°C
and 39.5°C (lanes 5 and 8). (B) Anti-nsp8 antibody was used to pull down viral proteins that were processed at the permissive and nonpermissive
temperatures. At 32°C, nsp8 was processed in wt-icMHV, icTS-LA6, and TS-LA6 (lanes 2 to 4). For infections initiated at 32°C and then shifted to 39.5°C,
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single complementation group and are presumed to occur
within a cistron (14). This principle was the basis for predicting
that nsp4, nsp5, and nsp10 are part of a single cistron com-
prised of nsp4 to nsp10/11 and known as complementation
group I (46). A cistron comprised of nsp4 to nsp10/11 has a
calculated molecular mass of 150 kDa, and the hypothesis
that nsp4 to nsp10/11 act as a single cistron is supported by the
fact that a p150 intermediate is detected in immunoprecipitation
experiments using antibody against nsp7 to nsp10 (6, 24, 50).
TS-LA6 behaves almost identically to wild-type MHV infec-
tions treated with CH to inhibit protein synthesis (5, 45). In
wild-type MHV-A59 replication, negative-strand synthesis
stops within 30 min of the addition of CH, which implies that
the virus requires an ongoing supply of proteins to form new
negative-strand replication complexes to continue negative-
strand synthesis (5, 45). Positive-strand synthesis continues un-
til all negative strands are depleted, suggesting that the posi-
tive-strand replication complex is stable and does not require
the continued renewal of cofactors to function (46). Sawicki
and colleagues reported previously that TS-LA6 negative-
strand synthesis stops almost immediately after a shift to the
nonpermissive temperature, while positive-strand synthesis
continues unabated until all negative strands are likely de-
pleted. This hypothesis is drawn from two experiments, one
evaluating overall RNA synthesis of several TS mutants and a
second using pulse-chase experiments before and after the
shift of plus and minus strands compared to infections treated
with CH (46). The pulse-label experiment for TS-LA6 showed
no difference in plus-strand synthesis and a rapid reduction in
negative-strand synthesis (46). Those authors suggested at
least two possibilities to account for TS mutants from comple-
mentation group I being defective in forming competent rep-
lication/transcription complexes capable of generating more
negative strands: (i) the TS mutation altered the ability of p150
to function in negative-strand but not positive-strand synthesis,
and (ii) the TS mutation blocked the ability of negative strands
to be used as templates for positive-strand synthesis (46). Fur-
ther analysis of RNA synthesis of the TS-LA6 mutant sug-
gested that negative strands were not made after the shift,
implying a defect in negative-strand elongation (46, 59).
Our immunoprecipitation results suggest an alternative
mechanism for the TS-LA6 mode of action. Using TS-LA6 and
icTS-LA6, we demonstrated that the processing of nsp5, nsp8,
nsp10, and nsp12 is ablated after a shift to the nonpermissive
temperature (Fig. 7A to D), which strongly implies that
3CLpro function in general is abrogated by this mutation.
Furthermore, our results demonstrate that 3CLpro-mediated
processing of pp1a and pp1ab is blocked by this mutation (Fig. 7A
to D), while processing by PLPs is not compromised (Fig. 7E).
Blocking the processing of 3CLpro should mimic infections
that were treated with E64d or CH, especially if nsp4 to nsp16
encode the labile factors that contribute to the negative-strand
replicase. In fact, there is little difference in viral RNA synthesis
of cells treated with CH and those infected with TS-LA6 at the
nonpermissive temperature (46). While CH would reduce the
quantities of proteins translated in general, ablating processing at
the nonpermissive temperature, as we have demonstrated occurs
with TS-LA6, would more closely mimic treatment of cells with
E64d, as translation would continue, but unprocessed polypro-
teins would likely accumulate (27). In our immunoprecipitation
experiments for the study of nsp5, nsp8, nsp10, we show that p150
accumulates after a shift to the nonpermissive temperature (Fig.
7), consistent with this observation.
In light of these findings, we hypothesize that the TS mutation
of nsp10 ablates all 3CLpro processing, similar to treatment with
E64d (27), which results in a block of all viral RNA synthesis at
the restrictive temperature. The noted dominant effects on neg-
ative-strand synthesis reflect the sensitivity of the negative-strand
replicase when new protein synthesis/processing is blocked, while
nsp8 was ablated in icTS-LA6 and TS-LA6, and p150 appeared to accumulate (lanes 6 and 7). wt-icMHV continued to process this protein at 37°C
and 39.5°C (lanes 5 and 8). (C) Immunoprecipitation analysis conducted with anti-nsp5 antibody. At 32°C, the results show that nsp5 was processed
in wt-icMHV, icTS-LA6, and TS-LA6 (lanes 2 to 4). After a shift to 39.5°C, processing of nsp5 was not seen in icTS-LA6 and TS-LA6 (lanes 6
and 7). wt-icMHV processing of nsp5 was observed at 37°C and 39.5°C (lanes 5 and 8). (D) Immunoprecipitation with anti-nsp12 antibody showed
that nsp12 was processed in wt-icMHV, icTS-LA6, and TS-LA6 at the permissive temperature (lanes 2 to 4). After a shift to the nonpermissive
temperature, processing of nsp12 was ablated in icTS-LA6 and TS-LA6 (lanes 6 and 7), while wt-icMHV continued to efficiently process this
protein at 37°C and 39.5°C (lanes 5 and 8). (E) Anti-nsp2 antibody was used to pull down viral proteins that were processed at the permissive and
nonpermissive temperatures by PLP1 and PLP2. (C) At 32°C, the results show that nsp2 is processed in wt-icMHV as well as mutants icTS-LA6
and TS-LA6. (D) For infections initiated at 32°C and then shifted to 39.5°C, the results show that the processing of nsp2 continued as observed
at 32°C, with wt-icMHV showing a greater increase in processed nsp2.
FIG. 8. Location of the TS mutation on the nsp10 structure. A
homology model of the MHV-A59 nsp10 protein was generated using
the coordinates of the X-ray crystal structure of SARS-CoV (PDB
accession number 2FYG) using the program Modeler. The mutants
icTS-LA6 (nsp10:Q65E) and nsp10-E2 (nsp10:D47A,H48A) were
mapped onto the structure. Both mutations occur within a predicted
disordered region, proximal to zinc-binding finger 1, and are exposed
to the surface.
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plus-strand replicase molecules are less sensitive. However, all
RNA synthesis will eventually stop because continued protein
processing is ultimately required for both.
Complementation studies showed that TS-LA6 does not
complement other TS viruses with mutations in p150, including
TS-ALB6 (nsp4) and TS-Alb16 (nsp5) as well as others (46).
However, TS-LA6 does complement other TS mutants with
changes that occur in pp1b, although the incorporation rates
and complementation indices (CIs) for these crosses are sig-
nificantly lower (46). For example, TS-LA6 crossed with TS-
ALB22 (mutation in nsp12) has CIs of 11 and 18 and an
incorporation rate of 9% compared to the cross between TS-
ALB6 and TS-ALB22, which has CIs of 694 and 108 and an
incorporation rate of 41% (46). This same result was shown in
other crosses between TS-LA6 and TS mutants that fall into
complementation groups other than group I, specifically with
mutants TS-ALB17 (nsp14) and TS-Ut145 (unknown), with
CIs of 3 and 7, and 6, respectively (46). Our results are con-
sistent with the inability of TS-LA6 to complement viruses with
mutations in p150, as the TS mutation prevents any processing
of these intermediates both in cis and in trans (Fig. 9A). Con-
sequently, viruses with TS mutations within nsp4 to nsp10
would lack the cognitive trans functional factor from TS-LA6.
In contrast, it is less clear why complementation between TS-
LA6 and TS mutants mapping in ORF1b was observed. The
TS-LA6 mutation appears to block the processing of ORF1b,
most likely in cis and in trans, as temperature shift experiments
demonstrated ablated processing in the presence of processed
3CLpro (Fig. 7D). These data suggest that mutant TS-LA6
(icTS-LA6) could not directly complement any other TS mu-
tant with mutations that occur within the 3CLpro cleavage
range (nsp4 to nsp16). The fact that low-level complementa-
tion has been reported to occur in crosses between TS-LA6
and TS mutants in pp1b suggests that 3CLpro from the pp1b
TS mutants can perform limited processing of ORF1b nsp’s of
TS-LA6 polyproteins in trans allowing the two viruses to com-
plement (Fig. 9B). However, we cannot rule out the possibility
that the recombination or reversion of TS viruses may be
occurring during coinfection, which would confound the CI,
resulting in slightly higher-than-expected indices; also, 3CLpro
may function less efficiently in trans to process proteins from
the C-terminal region of pp1ab. We hypothesize that crosses
between TS-LA6 and TS-ALB22, TS-ALB17, and TS-Ut145
are complementing via trans cleavage by the 3CLpro of the
pp1b TS mutant, which cleaves the appropriate nsp of TS-LA6
to rescue RNA synthesis.
Our results also challenge the current paradigm that nsp4 to
nsp11 (p150) function as a cistron, as TS-LA6 abrogates
3CLpro activity and therefore synthesizes large uncleaved
polyproteins and should not be capable of complementing
other TS mutants spanning nsp4 to nsp16 at the restrictive
temperature. Two additional mutants within the putative cis-
tron spanning nsp4 to nsp11, TS-ALB6 in nsp4 and TS-ALB16
in nsp5, do not complement TS-LA6 or each other but do
robustly complement TS viruses from other complementation
groups. The processing patterns of TS-ALB6 and TS-ALB16
need to be investigated in more detail to determine whether
they impact global processing similarly to TS-LA6, impact se-
lect processing of specific intermediates (nsp5 and nsp6), or
impact individual nsp function. Our data suggest that mutants
within the individual proteins nsp4 to nsp10 that do not affect
processing may exist, and these mutants should be capable of
complementing other TS mutants in other nsp’s (49, 53).
The fact that TS-ALB6 and TS-ALB16 do not complement
within p150 but do so in other complementation groups raises the
possibility that CoVs utilize differential proteolytic processing,
FIG. 9. Complementation with TS-LA6 revisited. Sawicki et al. established that crosses between TS mutants within nsp4, nsp5, and nsp10 failed
to complement each other as shown by the cis-trans test and biochemical complementation analysis. This was the basis for including them in
complementation group I and suggests that nsp4 to nsp10 act as a single cistron. (A) The TS mutation in nsp10 effectively renders the entire pp1ab
polyprotein unprocessed, and therefore, it cannot complement any other TS mutant from complementation group 1. (B) Our results suggest that
TS-LA6 cannot complement any virus bearing a TS mutation in pp1ab. However, limited proteolysis may occur in trans to process proteins in pp1b.
Complementation between TS-LA6 and TS-ALB22 suggests that 3CLpro of TS-ALB22 cleaves nsp12 of TS-LA6 in trans to rescue virus
replication. The dotted line represents trans cleavage of nsp12. Hatched boxes show proteins potentially cleaved in trans. }, 3CLpro cleavage site.
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cleaving the majority of products translated from pp1a by cis
interactions while processing less frequent pp1b products in trans.
Interestingly, the icTS-LA6 mutation is adjacent on the in-
ferred structure of MHV nsp10 to the mutations of nsp10-E2
(Fig. 8), a mutant that demonstrated a delayed processing
phenotype, resulting in replication intermediates not observed
in wt-icMHV (14a). The nsp10-E2 mutation removes an as-
partate and a histidine, which are replaced with alanine, while
the TS mutation adds the negative charge of glutamate. Both
mutants produce viral RNA in ratios equivalent to those of the
wild type, map from amino acid positions 50 to 70 of nsp10,
and occur in a disordered loop region proximal to zinc-binding
finger 1 (23). This region is altered substantially by both mu-
tations, as predicted by homology models of nsp10-E2 and
icTS-LA6. In the case of nsp10-E2, substituting alanines for
Asp47 and His48 directly alters hydrogen bonds, Lys43-His48,
Asp47-Ala49, and Asp47-Cys46, forcing the loop to collapse
inward, rearranging the surface. Replacing a glutamine with a
glutamic acid at position 65, as in icTS-LA6, adds a negative
charge to the surface of the protein (23) and forces the loop to
extend outward, probably due to repulsion between Glu65,
Asp66, and Glu60, which are in the same proximity. This allows
a new hydrogen bond to form between Glu65 and His48, which
likely extends the loop outward. These results suggest that the
region from amino acids 50 to 70 comprises a putative inter-
action site in wt-icMHV nsp10, and we predict that these
mutations significantly alter the binding interface between
nsp10 and another cofactor, which is required to facilitate
3CLpro activity.
Although previous reports have shown that polyprotein pro-
cessing is affected by TS mutants of MHV-A59 (4), this is the first
report to demonstrate that the Q65E mutation in nsp10 of TS-
LA6 results in a defect in nsp5 (3CLpro) function at the nonper-
missive temperature. This implicates nsp10 as being a critical
factor in 3CLpro activity. In general, the regulation of 3CLpro
activity in MHV is poorly understood. However, one potential
mechanism is that nsp10 allosterically regulates 3CLpro by inter-
acting with another nsp(s) in the p150 polyprotein to facilitate the
proteinase activity by inducing a conformational change necessary
for 3CLpro to function in cis. Two studies have shown that nsp10
interacts with other proteins including itself, nsp1, and nsp7 (6,
36). Future experiments have been designed to determine if
amino acids 50 to 70 maintain a site that is important for inter-
actions with other viral cofactors.
A second possibility is that nsp10 encodes a flexible disordered
region, conserved among all CoVs, which allows the polyprotein
to fold into the proper orientation to facilitate the cleavage of
p150 by 3CLpro. Studies conducted with yellow fever and hepa-
titis A viruses have shown that the mutagenesis of amino acids
distant from the polyprotein cleavage site and the active site of the
viral protease can reduce proteolytic activity, probably by altering
substrate conformation (13, 20). It is possible that the change to
glutamate at position 65 of nsp10 of TS-LA6 is thermostable at
the permissive temperature but unstable at the nonpermissive
temperature, altering the conformation of the p150 intermediate
or rendering it insoluble and therefore resistant to 3CLpro cleav-
age. A third possibility is that the TS mutation of nsp10 alters the
conformation of p150 at the nonpermissive temperature and that
this prevents membrane anchoring or dimerization, both of which
may be essential for the activation of 3CLpro function (1, 2, 40,
50, 54, 56, 58).
This is the first study to demonstrate that nsp10 is critical for
polyprotein processing and suggests that nsp10 plays pleiotropic
roles in the CoV life cycle, as additional studies have demon-
strated that nsp10 likely plays a role in viral RNA synthesis.
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